A program to increase hope for women experiencing intimate partner violence
Hope as a Path to Healing: Developing a Single-Session Intervention for Women Who Experience Intimate Partner Violence
This study is trying out a new program to help women who have experienced intimate partner violence feel more hopeful and empowered through a self-guided approach.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 65 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Trial ID | NCT06375876 on ClinicalTrials.gov |
What this trial studies
This study develops and tests a brief, self-guided intervention aimed at enhancing hope among women who have experienced intimate partner violence (IPV). It consists of two stages: the first focuses on creating the intervention, while the second involves pilot testing its feasibility, acceptability, and safety. Participants will engage in daily self-reports of hope, self-worth, empowerment, and emotional wellbeing for 14 days before and after completing the intervention. The goal is to evaluate changes in these constructs and gather feedback on the intervention process.
Who should consider this trial
Good fit: Ideal candidates are women who have experienced physical IPV by a male partner for at least three months and have access to a compatible smartphone.
Not a fit: Patients with significant psychiatric instability or those not comfortable with English may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could empower women experiencing IPV by enhancing their hope and overall emotional wellbeing.
How similar studies have performed: While the approach is innovative, similar interventions targeting emotional wellbeing in IPV survivors have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Pilot Stage: * Self-identify as a woman (cis- or trans-gender woman) * Currently in a relationship of at least 3 months duration in which they have experienced physical IPV by a male partner * Have a smartphone that is compatible with the MyCap app to be able to participate in daily surveys. Exclusion Criteria: Pilot Stage: * Have experienced significant psychiatric instability based on self-reported inpatient psychiatric hospitalization in the past 3 months * Reports having a conservator of person * Not comfortable conversing, reading, or writing in English * Participated in a Listening Session in the development phase of this study.
Where this trial is running
New Haven, Connecticut
- The Consultation Center at Yale — New Haven, Connecticut, United States (Recruiting)
Study contacts
- Principal investigator: Tami Sullivan, PhD — Department of Psychiatry, Yale School of Medicine
- Study coordinator: Tami Sullivan, PhD
- Email: tami.sullivan@yale.edu
- Phone: 203-789-7645
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.